Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2012
07/24/2012US8227467 Therapeutic agents useful for treating pain
07/24/2012US8227461 Isoxazoles
07/24/2012CA2686378C Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
07/24/2012CA2663044C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
07/24/2012CA2512242C Cyano anthranilamide insecticides
07/24/2012CA2476065C Inhibitors of histone deacetylase
07/24/2012CA2444108C Nociceptin analogs
07/24/2012CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
07/24/2012CA2386716C Magnesium salt of s-omeprazole
07/19/2012WO2012097121A2 Specific nnos inhibitors for the therapy and prevention of human melanoma
07/19/2012WO2012095781A1 Indazole derivatives as sodium channel inhibitors
07/19/2012WO2012065904A3 Cyanoenamines and their use as fungicides
07/19/2012WO2012064808A8 Tetrazolyl - tetrahydropyridine compounds for inflammation and immune - related uses
07/19/2012WO2012058529A3 Metalloenzyme inhibitor compounds
07/19/2012WO2012017166A3 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
07/19/2012US20120184747 Aniline compound
07/19/2012US20120184746 Process for the preparation of lenalidomide
07/19/2012US20120184744 Crystalline hydrochloride salts of c-met kinase inhibitors
07/19/2012US20120184740 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
07/19/2012US20120184732 Nitrogen-containing heterocyclic compound and salt thereof, and a fungicide for agricultural and horticultural use
07/19/2012US20120184583 Modulators of atp-binding cassette transporters
07/19/2012US20120184582 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
07/19/2012US20120184580 Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof
07/19/2012US20120184579 Quinolines and Their Therapeutic Use
07/19/2012US20120184574 Indole derivatives and methods for antiviral treatment
07/19/2012US20120184572 Aryl gpr119 agonists and uses thereof
07/19/2012US20120184571 Quinazolinone derivatives useful as vanilloid antagonists
07/19/2012US20120184563 Composition for external application comprising aripiprazole and organic acid as active ingredients
07/19/2012US20120184561 Phenylacetamides suitable as protein kinase inhibitors
07/19/2012US20120184556 Substituted enzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
07/19/2012US20120184553 Novel compounds
07/19/2012US20120184533 Small molecule inhibitors of parp activity
07/19/2012US20120184523 C-Met Modulators and Method of Use
07/19/2012US20120184520 Glycine compound
07/19/2012US20120184518 Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitors
07/19/2012US20120184516 sGC Stimulators
07/19/2012US20120183984 Hydrogen peroxide sensors based upon photo-induced electron transfer
07/19/2012US20120183751 Base generator, photosensitive resin composition, pattern forming material comprising the photosensitive resin composition, pattern forming method using the photosensitive resin composition and products comprising the same
07/19/2012US20120183579 Compounds for inflammation and immune-related uses
07/19/2012US20120183522 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
07/19/2012US20120183498 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
07/19/2012US20120181524 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using the same
07/19/2012US20120181516 Light-absorbing material and photoelectric conversion element
07/18/2012EP2476679A2 Substituted triazoles useful as AXL inhibitors
07/18/2012EP2476678A1 Substituted carbonyl compounds
07/18/2012EP2476677A1 Process for production of 4-(5-methylpyridin-2-ylamino)piperidine-1-carboxylic acid derivatives
07/18/2012EP2476671A1 1H-Quinazoline-2,4-diones
07/18/2012EP2476667A2 Aminoheteroaryl compounds as protein kinase inhibitors
07/18/2012EP2475655A1 Sterically hindered amine stabilizer
07/18/2012EP2475654A1 Herbicidal pyrimidone derivatives
07/18/2012EP2475653A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs
07/18/2012EP2475652A1 Pharmaceutically useful heterocycle-substituted lactams
07/18/2012EP2475647A1 Androgen receptor antagonists and uses thereof
07/18/2012EP2475644A1 Hsl inhibitors useful in the treatment of diabetes
07/18/2012EP2475643A1 Novel ethane diamine hepcidin antagonists
07/18/2012EP2475642A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
07/18/2012EP2475256A1 Hepatitis c virus inhibitors
07/18/2012EP2475254A1 Hepatitis c virus inhibitors
07/18/2012EP2262772B1 Quinoline derivatives as axl kinase inhibitors
07/18/2012EP2121600B1 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
07/18/2012EP1467966B1 Water-soluble dithioesters and method for polymerization thereof
07/18/2012CN1951917B Pyridinone derivatives for treatment of atherosclerosis
07/18/2012CN1753886B Process for producing acid adduct salt of polyacidic base compound
07/18/2012CN1531533B Crystalline form of omeprazole
07/18/2012CN1443167B Azacyclic compounds for use in treatment of 5-serotonin related diseases
07/18/2012CN102596978A Metal complex, polymer, and element obtained using same
07/18/2012CN102596936A Antiviral compounds
07/18/2012CN102596935A Compounds useful for treating premature aging and in particular progeria
07/18/2012CN102596934A Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists
07/18/2012CN102596933A Herbicidal pyrimidone derivatives
07/18/2012CN102596932A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
07/18/2012CN102596919A Aromatase inhibitor
07/18/2012CN102596913A Cannabinoid receptor modulators
07/18/2012CN102596910A Androgen receptor modulating compounds
07/18/2012CN102596909A Positive allosteric modulators (PAM)
07/18/2012CN102596906A Use of indole derivatives as NURR-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
07/18/2012CN102596200A Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
07/18/2012CN102592831A Cobalt ion liquid redox couple and preparation and application thereof
07/18/2012CN102584799A Aromatic nitrogenous six-membered ring compounds
07/18/2012CN102584797A Method for preparing N-[4-(4-(3-pyridyl)-1-imidazolyl) butyl] phthalimide
07/18/2012CN102584796A Bis-Schiff bases synthesized by condensing indole-3-carboxaldehyde and pyridine diamine and preparation method thereof
07/18/2012CN102584795A Preparing method of crizotinib
07/18/2012CN102584794A Active light yellow LA and preparation process thereof
07/18/2012CN102584793A Rabeprazole sodium crystal compound and preparing method thereof
07/18/2012CN102584792A Method for preparing high-purity esomeprazole
07/18/2012CN102584791A Method for refining pantoprazole optical enantiomer
07/18/2012CN102584790A S-pantoprazole sodium trihydrate, and preparation method and application thereof
07/18/2012CN102584789A Quinolinecarboxaldehyde schiff base, preparation method and application thereof
07/18/2012CN102584788A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
07/18/2012CN102584787A Ultrasonic preparation method for imatinib mesylate crystal
07/18/2012CN102584786A Activity-brilliant-red LA and preparation method thereof
07/18/2012CN102584785A Activity-deep-blue LA and preparation process thereof
07/18/2012CN102584754A Fused aromatic compounds having anti-diabetic activity
07/18/2012CN102584718A Method for synthesizing quinazoline-4-(3H)-ketone
07/18/2012CN102584698A 2-substutied-3-quinolinic acid ethyl ester compound, preparation method and applications thereof
07/18/2012CN102584694A Preparation methods for important intermediates of anthranilic diamide compound
07/18/2012CN102584690A Pyridine-2-ketone compound, as well as preparation method and applications of pyridine-2-ketone compound
07/18/2012CN102584687A Ethylene derivatives used as selective estrogen receptor modulators
07/18/2012CN101863878B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
07/18/2012CN101678011B Spiroindalones
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 1080